Role of mitochondria and NADPH oxidase derived reactive oxygen species in hyperoxaluria induced nephrolithiasis: Therapeutic intervention with combinatorial therapy of N-acetyl cysteine and Apocynin

Mitochondrion

Volumn 27, Issue , 2016, Pages 15-24

  Sharma, Minu ^a   Kaur, Tanzeer ^a   Singla, S K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Apocynin; Hyperoxaluria; Mitochondrion; N acetylcysteine; NADPH oxidase; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; APOCYNIN; CYTOCHROME C OXIDASE; GLUTATHIONE; LIPID; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE; ACETOPHENONE DERIVATIVE; ANTIOXIDANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFICACY; DRUG MECHANISM; KIDNEY FUNCTION; LIPID PEROXIDATION; MALE; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION; NEPHROLITHIASIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; COMBINATION DRUG THERAPY; COMPLICATION; DISEASE MODEL; HYPEROXALURIA; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; TREATMENT OUTCOME; WISTAR RAT;

ACETOPHENONES; ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; HYPEROXALURIA; MALE; MITOCHONDRIA; NADPH OXIDASE; NEPHROLITHIASIS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; TREATMENT OUTCOME;

EID: 84955060297     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2016.01.002     Document Type: Article

References (61)

1. Aggarwal A., Singla S.K., Gandhi M., Tandon C. Preventive and curative effects of Achyranthes aspera Linn. extract in experimentally induced nephrolithiasis. Indian J. Exp. Biol. 2012, 50:201-208.
2. Aggarwal D., Kaushal R., Kaur T., Bijarnia R.K., Puri S., Singla S.K. The most potent antilithiatic agent ameliorating renal dysfunction and oxidative stress from Bergenia ligulata rhizome. J. Ethnopharmacol. 2014, 158 Pt A:85-93.
3. Asplin J.R. Hyperoxaluric calcium nephrolithiasis. Endocrinol. Metab. Clin. N. Am. 2002, 31:927-949.
4. Bijarnia R.K., Kaur T., Aggarwal K., Singla S., Tandon C. Modulatory effects of N-acetylcysteine on hyperoxaluric manifestations in rat kidney. Food Chem. Toxicol. 2008, 46:2274-2278.
5. Bijarnia R.K., Bachtler M., Chandak P.G., van Goor H., Pasch A. Sodium thiosulfate ameliorates oxidative stress and preserves renal function in hyperoxaluric rats. PLoS One 2015, 10.
6. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 1978, 52:302-310.
7. Cao L.C., Honeyman T.W., Cooney R., Kennington L., Scheid C.R., Jonassen J.A. Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity. Kidney Int. 2004, 66:1890-1900.
8. Carlberg I., Mannervik B. Glutathione reductase. Methods Enzymol. 1985, 113:484-490.
9. Daiber A. Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species. Biochim. Biophys. Acta 2010, 1797:897-906.
10. Dodd-o J.M., Welsh L.E., Salazar J.D., Walinsky P.L., Peck E.A., Shake J.G., Caparrelli D.J., Ziegelstein R.C., Zweier J.L., Baumgartner W.A., Pearse D.B. Effect of NADPH Oxidase Inhibition on Cardiopulmonary Bypass-Induced Lung Injury 2004.
11. Doughan A.K., Harrison D.G., Dikalov S.I. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ. Res. 2008, 102:488-496.
12. Flohe L., Gunzler W.A. Assays of glutathione peroxidase. Methods Enzymol. 1984, 105:114-121.
13. Galindo M.F., Jordán J., González-Garciá C., Ceñaa V. Reactive oxygen species induce swelling and cytochrome c release but not transmembrane depolarization in isolated rat brain mitochondria. Br. J. Pharmacol. 2003, 139:797-804.
14. Gower L.B., Amos F.F., Khan S.R. Mineralogical signatures of stone formation mechanisms. Urol. Res. 2010, 38:281-292.
15. Hodgkinson A., Williams A. An improved colorimetric procedure for urine oxalate. Clin. Chim. Acta 1972, 36:127-132.
16. Hougee S., Hartog A., Sanders A., Graus Y.M., Hoijer M.A., Garssen J., van den Berg W.B., van Beuningen H.M., Smit H.F. Oral administration of the NADPH-oxidase inhibitor apocynin partially restores diminished cartilage proteoglycan synthesis and reduces inflammation in mice. Eur. J. Pharmacol. 2006, 531:264-269.
17. Huang H.S., Ma M.C., Chen J. Low-vitamin E diet exacerbates calcium oxalate crystal formation via enhanced oxidative stress in rat hyperoxaluric kidney. Am. J. Physiol. Ren. Physiol. 2009, 296:F34-F45.
18. Joshi S., Saylor B.T., Wang W., Peck A.B., Khan S.R. Apocynin-treatment reverses hyperoxaluria induced changes in NADPH oxidase system expression in rat kidneys: a transcriptional study. PLoS One 2012, 7.
19. Khan S.R. Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol. Res. 2005, 33:349-357.
20. Khan S.R. Renal tubular damage/dysfunction: key to the formation of kidney stones. Urol. Res. 2006, 34:86-91.
21. Khan S.R. Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis. Transl. Androl. Urol. 2014, 3:256-276.
22. Khan S.R., Khan A., Byer K.J. Temporal changes in the expression of mRNA of NADPH oxidase subunits in renal epithelial cells exposed to oxalate or calcium oxalate crystals. Nephrol. Dial. Transplant. 2011, 26:1778-1785.
23. Khan A., Byer K., Khan S.R. Exposure of Madin-Darby canine kidney (MDCK) cells to oxalate and calcium oxalate crystals activates nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase. Urology 2014, 83(510):e511-e517.
24. Khand F.D., Gordge M.P., Robertson W.G., Noronha-Dutra A.A., Hothersall J.S. Mitochondrial superoxide production during oxalate-mediated oxidative stress in renal epithelial cells. Free Radic. Biol. Med. 2002, 32:1339-1350.
25. King T.E., Howard R.L. Preparations and properties of soluble NADH dehydrogenases from cardiac muscle. Methods Enzymol. 1967, 10:275-284.
26. King T.E., Ohnishi T., Winter D.B., Wu J.T. Biochemical and EPR probes for structure-function studies of iron sulfur centers of succinate dehydrogenase. Adv. Exp. Med. Biol. 1976, 74:182-227.
27. Kirby D.M., Thorburn D.R., Turnbull D.M., Taylor R.W. Biochemical assays of respiratory chain complex activity. Methods Cell Biol. 2007, 80:93-119.
28. Kono Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch. Biochem. Biophys. 1978, 186:189-195.
29. Lemasters J.J., Theruvath T.P., Zhong Z., Nieminen A.L. Mitochondrial calcium and the permeability transition in cell death. Biochim. Biophys. Acta 2009, 1787:1395-1401.
30. Li J.M., Gall N.P., Grieve D.J., Chen M., Shah A.M. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 2002, 40:477-484.
31. Li C.Y., Deng Y.L., Sun B.H. Taurine protected kidney from oxidative injury through mitochondrial-linked pathway in a rat model of nephrolithiasis. Urol. Res. 2009, 37:211-220.
32. Liu Y., Peterson D.A., Kimura H., Schubert D. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 1997, 69:581-593.
33. Massey L.K., Roman-Smith H., Sutton R.A. Effect of dietary oxalate and calcium on urinary oxalate and risk of formation of calcium oxalate kidney stones. J. Am. Diet. Assoc. 1993, 93:901-906.
34. McMartin K.E., Wallace K.B. Calcium oxalate monohydrate, a metabolite of ethylene glycol, is toxic for rat renal mitochondrial function. Toxicol. Sci. 2005, 84:195-200.
35. Moron M.S., Depierre J.W., Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim. Biophys. Acta Gen. Subj. 1979, 582:67-78.
36. Muthukumar A., Selvam R. Effect of depletion of reduced glutathione and its supplementation by glutathione monoester on renal oxalate retention in hyperoxaluria. J. Nutr. Biochem. 1997, 8:445-450.
37. Nazzal L., Puri S., Goldfarb D.S. Enteric hyperoxaluria: an important cause of end-stage kidney disease. Nephrol. Dial. Transplant. 2015.
38. Niimi K., Yasui T., Hirose M., Hamamoto S., Itoh Y., Okada A., Kubota Y., Kojima Y., Tozawa K., Sasaki S., Hayashi Y., Kohri K. Mitochondrial permeability transition pore opening induces the initial process of renal calcium crystallization. Free Radic. Biol. Med. 2012, 52:1207-1217.
39. Pigeolet E., Corbisier P., Houbion A., Lambert D., Michiels C., Raes M., Zachary M.D., Remacle J. Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals. Mech. Ageing Dev. 1990, 51:283-297.
40. Rathore R., Zheng Y.M., Niu C.F., Liu Q.H., Korde A., Ho Y.S., Wang Y.X. Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through the mitochondrial ROS-PKCepsilon signaling axis in pulmonary artery smooth muscle cells. Free Radic. Biol. Med. 2008, 45:1223-1231.
41. Robijn S., Hoppe B., Vervaet B.A., D'Haese P.C., Verhulst A. Hyperoxaluria: a gut-kidney axis?. Kidney Int. 2011, 80:1146-1158.
42. Sedeek M., Nasrallah R., Touyz R.M., Hebert R.L. NADPH oxidases, reactive oxygen species, and the kidney: friend and foe. J. Am. Soc. Nephrol. 2013, 24:1512-1518.
43. Shah J.G., Patel B.G., Patel S.B., Patel R.K. Antiurolithiatic and antioxidant activity of Hordeum vulgare seeds on ethylene glycol-induced urolithiasis in rats. Indian J. Pharmacol. 2012, 44:672-677.
44. Sharma M., Kaur T., Singla S.K. Protective effects of N-acetylcysteine against hyperoxaluria induced mitochondrial dysfunction in male wistar rats. Mol. Cell. Biochem. 2015, 405:105-114.
45. Sottocasa G.L., Kuylenstierna B., Ernster L., Bergstrand A. An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study. J. Cell Biol. 1967, 32:415-438.
46. Thamilselvan S., Hackett R.L., Khan S.R. Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J. Urol. 1997, 157:1059-1063.
47. Thamilselvan V., Menon M., Thamilselvan S. Selective Rac1 inhibition protects renal tubular epithelial cells from oxalate-induced NADPH oxidase-mediated oxidative cell injury. Urol. Res. 2012, 40:415-423.
48. Umekawa T., Chegini N., Khan S.R. Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Int. 2002, 61:105-112.
49. Umekawa T., Byer K., Uemura H., Khan S.R. Diphenyleneiodium (DPI) reduces oxalate ion- and calcium oxalate monohydrate and brushite crystal-induced upregulation of MCP-1 in NRK 52E cells. Nephrol. Dial. Transplant. 2005, 20:870-878.
50. Veena C.K., Josephine A., Preetha S.P., Rajesh N.G., Varalakshmi P. Mitochondrial dysfunction in an animal model of hyperoxaluria: a prophylactic approach with fucoidan. Eur. J. Pharmacol. 2008, 579:330-336.
51. Verhulst A., Asselman M., Persy V.P., Schepers M.S., Helbert M.F., Verkoelen C.F., De Broe M.E. Crystal retention capacity of cells in the human nephron: involvement of CD44 and its ligands hyaluronic acid and osteopontin in the transition of a crystal binding- into a nonadherent epithelium. J. Am. Soc. Nephrol. 2003, 14:107-115.
52. Verkoelen C.F., Van Der Boom B.G., Romijn J.C. Identification of hyaluronan as a crystal-binding molecule at the surface of migrating and proliferating MDCK cells. Kidney Int. 2000, 58:1045-1054.
53. Vyas B., Vyas R., Joshi S., Santani D. Antiurolithiatic activity of whole-plant hydroalcoholic extract of Pergularia daemia in rats. J. Young Pharm. 2011, 3:36-40.
54. Wang H., Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 1999, 27:612-616.
55. Wenzel P., Mollnau H., Oelze M., Schulz E., Wickramanayake J.M., Muller J., Schuhmacher S., Hortmann M., Baldus S., Gori T., Brandes R.P., Munzel T., Daiber A. First evidence for a crosstalk between mitochondrial and NADPH oxidase-derived reactive oxygen species in nitroglycerin-triggered vascular dysfunction. Antioxid. Redox Signal. 2008, 10:1435-1447.
56. Williams H.E. Oxalic acid and the hyperoxaluric syndromes. Kidney Int. 1978, 13:410-417.
57. Wright P.J., Plummer D.T. The use of urinary enzyme measurements to detect renal damage caused by nephrotoxic compounds. Biochem. Pharmacol. 1974, 23:65-73.
58. Yamamori T., Inanami O., Nagahata H., Cui Y., Kuwabara M. Roles of p38 MAPK, PKC and PI3-K in the signaling pathways of NADPH oxidase activation and phagocytosis in bovine polymorphonuclear leukocytes. FEBS Lett. 2000, 467:253-258.
59. Zahler W., Cleland W. A specific and sensitive assay for disulfides. J. Biol. Chem. 1968, 243:716-719.
60. Zhang C.Y., Kong T., Wu W.H., Lan M.B. The protection of polysaccharide from the Brown Seaweed Sargassum graminifolium against ethylene glycol-induced mitochondrial damage. Mar. Drugs 2013, 11:870-880.
61. Zuo J., Khan A., Glenton P.A., Khan S.R. Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-L-proline-induced hyperoxaluria in the male Sprague-Dawley rats. Nephrol. Dial. Transplant. 2011, 26:1785-1796.